表纸
市场调查报告书
商品编码
997907

食道静脉瘤:全球临床实验趋势 (2021年前半期)

Esophageal Varices - Global Clinical Trials Review, H2, 2021

出版日期: | 出版商: GlobalData | 英文 102 Pages | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

  • 全貌
  • 简介
  • 目录
简介

本报告提供食道静脉瘤相关临床研究最新趋势相关分析,疾病、治疗方法概要,及主要已开发国家、新兴国家 (G7/E7各国) 的临床实验状况,各地区、各期 (各相)、各阶段的进展,有潜力的赞助商 (临床试验赞助者),各企业及研究机关的研究进行状况,有潜力的药剂比较等资讯汇整。

目录

目录

表格一览

图的一览

  • 分析概要
  • 分析范围
  • 各地区的临床实验情形
  • 各国临床实验数量和平均实验人数
  • 亚太地区主要5个国家的临床实验数量
  • 欧洲主要5个国家的临床实验数量
  • 北美的主要国家的临床实验数量
  • 中东、非洲的主要国家的临床实验数量
  • 中南美的主要国家的临床实验数量
  • G7各国的临床实验数量:肠胃疾病临床实验数量中食道静脉瘤的比率
  • G7各国的临床实验数量:各相 (各期)
  • G7各国的临床实验数量:各进展状况
  • E7各国的临床实验数量:肠胃疾病临床实验数量中食道静脉瘤的比率
  • E7各国的临床实验数量:各相 (各期)
  • E7各国的临床实验数量:各进展状况
  • 各相 (各期)临床实验数量
  • 进行中的临床实验:各相 (各期)
  • 各进展状况临床实验数量
  • 临床实验的目标的达成情形
  • 一定期间所采用的实验对象
  • 赞助商的各种类的临床实验数量
  • 有潜力的赞助商
  • 食道静脉瘤的治疗药临床实验的主要参与企业
  • 有潜力的药剂
  • 临床实验简介概要

附录

目录
Product Code: GDHC6769CTIDB

GlobalData's clinical trial report, "Esophageal Varices - Global Clinical Trials Review, H2, 2021" provides an overview of Esophageal Varices Clinical trials scenario. This report provides top line data relating to the clinical trials on Esophageal Varices . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Esophageal Varices to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Esophageal Varices to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Esophageal Varices Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source

List of Tables

List of Tables

  • Esophageal Varices Therapeutics, Global, Clinical Trials by Region, 2021*
  • Esophageal Varices Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Esophageal Varices Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Europe, Top Five Countries, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, North America, Top Countries, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Central and South America, Top Countries, 2021*
  • Proportion of Esophageal Varices to Gastrointestinal Clinical Trials, G7 Countries (%), 2021*
  • Esophageal Varices Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Esophageal Varices Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Proportion of Esophageal Varices to Gastrointestinal Clinical Trials, E7 Countries (%), 2021*
  • Esophageal Varices Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
  • Esophageal Varices Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
  • Esophageal Varices Therapeutics, Global, Clinical Trials by Phase, 2021*
  • Esophageal Varices Therapeutics, Global, Clinical Trials In Progress by Phase 2021*
  • Esophageal Varices Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
  • Esophageal Varices Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*

List of Figures

List of Figures

  • Esophageal Varices Therapeutics, Global, Clinical Trials by Region (%), 2021*
  • Esophageal Varices Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Esophageal Varices Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2021*
  • Esophageal Varices Therapeutics Clinical Trials, North America, Top Countries (%), 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2021*
  • Proportion of Esophageal Varices to Gastrointestinal Clinical Trials, G7 Countries (%), 2021*
  • Esophageal Varices Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Esophageal Varices Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Proportion of Esophageal Varices to Gastrointestinal Clinical Trials, E7 Countries (%), 2021*
  • Esophageal Varices Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
  • Esophageal Varices Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
  • Esophageal Varices Therapeutics, Global, Clinical Trials by Phase (%), 2021*
  • Esophageal Varices Therapeutics, Global, Clinical Trials In Progress by Phase, 2021*
  • Esophageal Varices Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
  • Esophageal Varices Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • Esophageal Varices Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*
  • GlobalData Methodology